| Literature DB >> 27277755 |
Kan Fang1, Peifeng Liu1, Suyan Dong1, Yanjie Guo1, Xinxin Cui1, Xiaoying Zhu1, Xuan Li1, Lianghan Jiang2, Te Liu3, Yuncheng Wu1.
Abstract
Glioma stem cells (GSCs) are a special subpopulation of glioma cells that are key to the sensitivity of tumors to treatments and to the possibility of tumor recurrence. Identifying new strategies that inhibit the growth of GSCs are therefore important for developing novel therapies for glioblastoma multiforme (GBM). In this study, CD133+ human glioma stem cells were isolated and cultured. Magnetic nanoparticles were used to mediate the expression of siRNAs targeting the HOTAIR (si-HOTAIR) sequence in human gliomas. Effect of downregulation of HOTAIR expression on proliferation, invasion and in vivo tumorigenicity of human GSCs and underlying molecular mechanisms were further evaluated. The results of the MTT assay and flow cytometric analysis showed that downregulation of HOTAIR expression inhibited cell proliferation and induced cell cycle arrest. Transwell assays demonstrated that downregulation of HOTAIR expression resulted in a decrease in the invasive capability of GSCs. Moreover, magnetic nanoparticle-mediated low expression of HOTAIR effectively reduced the tumorigenic capacity of glioma stem cells in vivo. In addition, the results of qRT-PCR and western blot analysis demonstrated that downregulation of HOTAIR expression significantly increased the expression of PDCD4 in GSCs, in addition to reducing the expression of CCND1 and CDK4. An in-depth mechanistic analysis showed that downregulation of HOTAIR expression reduced the recruitment of downstream molecules, EZH2 and LSD1, thereby activating the expression of PDCD4 at the transcriptional level. In conclusion, downregulation of HOTAIR expression effectively promoted the expression of PDCD4, thereby inhibiting the proliferation, invasion and in vivo tumorigenicity of human GSCs.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27277755 PMCID: PMC4922836 DOI: 10.3892/ijo.2016.3571
Source DB: PubMed Journal: Int J Oncol ISSN: 1019-6439 Impact factor: 5.650
The sequences of qRT-PCR primers.
| Gene product | Forward (F) and reverse (R) primers |
|---|---|
| 18s rRNA | F: CAGCCACCCGAGATTGAGCA |
| Cd44 | F: GACAAGTTTTGGTGGCACG |
| Cd133 | F: CCATTGGCATTCTCTTTGAA |
| Nestin | F: AAGATGTCCCTCAGCCTGG |
| Bdnf | F: GTCTCTGGGGATGCAGAG |
| Pdcd4 | F: GTGCAAGCGAAATTAAGGGA |
| Ccnd1 | F: TCCTCTCCAAAATGCCAGAG |
| Cdk4 | F: TGCAGTCCACATATGCAACA |
Primary antibodies, their source and dilutions.
| Antibodies | Companies | Applications |
|---|---|---|
| Rabbit anti-human PDCD4 (#9535) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IF (1:100) |
| Rabbit anti-human BDNF (#3897) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IF (1:100) |
| Rabbit anti-human CCND1 (#2978) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | WB (1:1,000) |
| Rabbit anti-human CDK4 (#12790) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | WB (1:1,000) |
| Rabbit anti-human Ki67 (#9129) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IF (1:100) |
| Rabbit anti-human H3K4Me2 (#9725) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IP (1:100) |
| Rabbit anti-human H3K4Me3 (#9751) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IP (1:100) |
| Rabbit anti-human EZH2 (#5246) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IP (1:100) |
| Rabbit anti-human LSD1 (#2184) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | IP (1:100) |
| Rabbit anti-human GAPDH (#5174) | Cell Signaling Technology, Inc. (Danvers, MA, USA) | WB (1:1,000) |
Figure 1Human glioma stem cells express high levels of HOTAIR. (A) CD133+ human glioma stem cells were isolated from glioma tissues using a flow cytometry-based cell sorting technique. (B) In a serum-free culture system, CD133+ human glioma stem cells grew clonally in suspension (original magnification, x200). (C) The results of the CCK-8 assay indicated that CD133+ human glioma stem cells possessed a significantly greater proliferative capability compared with CD133− human glioma cells. (D) The results of qRT-PCR revealed that the expression of the neural stem cell-related markers CD44, CD133, nestin and Bdnf was significantly elevated in CD133+ human glioma stem cells compared with CD133− human glioma cells. (E) The results of northern blot analysis demonstrated that the intensity of the HOTAIR hybridization signal was significantly stronger in CD133+ human glioma stem cells in comparison with CD133− human glioma cells. *P<0.05, n=3.
Figure 2Downregulation of HOTAIR expression significantly inhibits the proliferation and invasion of CD133+ human glioma stem cells. (A) TEM revealed that multiple high-density electron clouds were present in the group of cells subjected to SPION-mediated si-HOTAIR transfection. The results indicated that SPION successfully delivered si-HOTAIR into the cells. (B) Flow cytometric analysis demonstrated that compared with the control group, a considerably higher percentage of CD133+ human glioma stem cells transfected with SPION-si-HOTAIR conjugates were in the G0/G1 and G2/M phases of the cell cycle. In contrast, the percentage of S-phase cells was significantly lower in the group of CD133+ human glioma stem cells subjected to SPION-mediated si-HOTAIR transfection compared with the control group. (C) The results of Transwell assays showed that the number of invading cells was significantly lower in the group subjected to SPION-mediated si-HOTAIR transfection compared with the control group. *P<0.05, n=3.
Figure 3Downregulation of HOTAIR expression significantly inhibits the expression of PDCD4 and cell cycle regulatory proteins in human glioma stem cells. (A) Northern blot analysis showed that the hybridization signal yielded by the HOTAIR probe was significantly lower in CD133+ human glioma stem cells transfected with SPION/si-HOTAIR conjugates in comparison with the control group. (B) The CCK-8 assay showed that the cell proliferation inhibition rate was significantly higher in the group of CD133+ human glioma stem cells subjected to SPION-mediated si-HOTAIR transfection compared with the control group. (C) The results of qRT-PCR showed that compared with the control group, the expression level of PDCD4 mRNA was significantly higher, while the expression levels of Bdnf, CCND1 and CDK4 mRNAs were considerably lower in the group of CD133+ human glioma stem cells subjected to SPION-mediated si-HOTAIR transfection. (D) The results of western blot analysis showed that compared with the control group, the expression level of the PDCD4 protein was significantly higher, while the expression levels of the Bdnf, CCND1 and CDK4 proteins were considerably lower in the group of CD133+ human glioma stem cells subjected to SPION-mediated si-HOTAIR transfection. *P<0.05, **P<0.01, #P>0.05, n=3.
Figure 4Downregulation of HOTAIR expression reduces the recruitment of the EZH2 and LSD1 proteins, thereby regulating the transcription of PDCD4. (A) RIP results indicated that the binding of HOTAIR fragments to EZH2 and LSD1 was significantly decreased in SPION-mediated si-HOTAIR transfection CD133+ human glioma stem cells compared with the control group. IgGs from the corresponding species were used as negative controls. (B) The results of the CHIP assay showed that compared with the control group, there was an elevated level of H3K4me2 and a decreased level of H3K27me3 in the promoter region of PDCD4 in the group of CD133+ human glioma stem cells subjected to SPION-mediated si-HOTAIR transfection. (C) The mechanisms by which HOTAIR transcriptionally regulates PDCD4 are as follows: the EZH2 methyltransferase binds to the 5′ terminus of HOTAIR and mediates the trimethylation of H3K27 located in the promoter region of PDCD4; LSD1 binds to the 3′ terminus of HOTAIR and mediates the demethylation of H3K4me2 in the promoter region of PDCD4; and the combined effects of EZH2 and LSD1 silence the transcription of the PDCD4 gene. *P<0.05, **P<0.01, #P>0.05, n=3.
Figure 5Downregulation of HOTAIR expression significantly inhibits the tumorigenic capacity of CD133+ human glioma stem cells. (A) Si-mock- and si-HOTAIR-transfected CD133+ human glioma stem cells formed subcutaneous xenograft tumors in nude mice. The yellow box and red box indicate the respective locations of these tumors. (B) Compared with the control group, CD133+ human glioma stem cells expressing a low level of HOTAIR produced significantly smaller subcutaneous xenograft tumors in nude mice. (C) The weight of the subcutaneous xenograft tumors derived from CD133+ human glioma stem cells expressing a low level of HOTAIR was significantly lower compared with the control group. (D) TEM results showed that multiple circular-shaped, high-density electron clouds with the dimension of 80–100 nm were present in xenograft tumors derived from CD133+ human glioma stem cells expressing a low level of HOTAIR. The substance corresponding to the electron clouds was SPION. (E) H&E staining showed that the two groups of cells were both capable of forming xenograft tumors equivalent to human glioma. However, xenograft tumors derived from si-HOTAIR-transfected glioma stem cells exhibited a significantly lower degree of malignancy compared with those derived from si-mock-transfected glioma stem cells. The results of immunohistochemical analysis showed that the expression of PDCD4 was significantly higher, while the expression of BDNF and Ki67 was significantly lower in xenograft tumors derived from si-HOTAIR-transfected glioma stem cells compared with tumors derived from si-mock-transfected glioma stem cells; x200 (scale bar, 20 μm). *P<0.05, n=4.